Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today -0.0009 / -3.61%
Volume 86.7K
CGNH On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

cardiogenics holdings inc (CGNH) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
04/29/14 - $0.20
52 Week Low
12/11/14 - $0.01
Market Cap
1.5M
Average Volume 10 Days
189.4K
EPS TTM
--
Shares Outstanding
63.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIOGENICS HOLDINGS INC (CGNH)

Related News

No related news articles were found.

cardiogenics holdings inc (CGNH) Related Businessweek News

No Related Businessweek News Found

cardiogenics holdings inc (CGNH) Details

CardioGenics Holdings, Inc., a development stage company, engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was founded in 1997 and is headquartered in Mississauga, Canada.

4 Employees
Last Reported Date: 02/12/15
Founded in 1997

cardiogenics holdings inc (CGNH) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $137.1K
Chief Financial Officer
Total Annual Compensation: $32.9K
Secretary and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

cardiogenics holdings inc (CGNH) Key Developments

CardioGenics Holdings Inc announced delayed 10-Q filing

On 03/17/2015, CardioGenics Holdings Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

CardioGenics Holdings Inc announced delayed annual 10-K filing

On 01/29/2015, CardioGenics Holdings Inc announced that they will be unable to file their next 10-K by the deadline required by the SEC.

CardioGenics Holdings Inc. Appoints Karim Murabet as Director

On January 12, 2015 the board of directors of CardioGenics Holdings Inc. appointed Karim Murabet as a director of the company. Mr. Murabet will serve as an independent director of the company. Mr. Murabet currently resides in the United Arab Emirates and is a Partner and Director responsible for business development and public relations in ICap Group FZC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGNH:US $0.02 USD -0.0009

CGNH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CGNH.
View Industry Companies
 

Industry Analysis

CGNH

Industry Average

Valuation CGNH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOGENICS HOLDINGS INC, please visit www.cardiogenics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.